Is a complete IDX/OMED research report available?

Question

Accepted Answer

No complete published report is available for idx/OMED (IDX/OMED) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	5.7T
Revenue (ttm)	2.2T
Net income (ttm)	392.6B
EPS (ttm)	IDR 14.5
Shares out	27B
P/E (trailing)	14.5x
P/E (forward)	14.0x
Dividend	IDR 3.57 (1.70%)
Volume	12,204,600

Metric	Value
Country	Indonesia
Country code	ID
Employees	1,350
Employees Change	152%
Employees Change Percent	12.69
Enterprise value	IDR 4.6T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	ID1000176209
Last refreshed	2026-07-27
Market cap	IDR 5.7T
Price	IDR 210
Price currency	IDR
Rev Per Employee	1,629,444,238.43x
Sector	Healthcare
Sector PE	34.21
Sector PE Fwd	13.25
Sic	3842
Symbol	idx/OMED
Website	https://www.onemed.co.id

Metric	Value
Earnings Yield	6.92%
EV Earnings	11.73x
EV/EBIT	10.59x
EV/EBITDA	9.04x
EV/FCF	20.44x
EV/Sales	2.09x
FCF yield	3.97%
Forward P/E	13.95x
P/B ratio	1.99x
P/E ratio	14.46x
P/S ratio	2.58x
PE Ratio3 Y	17.11x
PE Ratio5 Y	17.58x

Metric	Value
EBIT Margin	19.77%
EBITDA Margin	22.31%
FCF margin	10.24%
Gross margin	35.49%
Gross Profit	IDR 780.7B
Gross Profit Growth	24.49%
Gross Profit Growth Q	44.56%
Gross Profit Growth3 Y	13.36%
Net Income	IDR 392.6B
Net Income Growth	18.61%
Net Income Growth Q	35.19%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Net Income Growth3 Y	14.8%
Pretax Margin	22.23%
Profit Margin	17.85%
Profit Per Employee	IDR 290.8M
Profitable Quarters	IDR 15
Profitable Years	7
ROA	8.69
Roa5y	12.72
ROCE	14.05
ROE	14.57
Roe5y	21.86
ROIC	20.79
Roic5y	43.18

Metric	Value
Cagr1y	22.44%
Cagr3y	6.26%
EPS Growth	18.74
EPS Growth Q	35.44
EPS Growth Quarters	6
EPS Growth Years	2
EPS Growth3 Y	16.26
FCF Growth	-30.36%
FCF Growth Q	-66.77%
OCF Growth	-19.09%
OCF Growth Q	-58.18%
Revenue Growth	16.1x
Revenue Growth Q	31.16x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	9.27x

IDX/OMED (IDX/OMED)

Coverage state: Market snapshot only — no published research

Generate the first IDX/OMED analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IDX/OMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IDX/OMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IDX/OMED

Frequently asked questions

Metric	Value
Asset Turnover	IDR 0.7
Assets	IDR 3.3T
Cash	IDR 1.4T
Current Assets	IDR 2.5T
Current Liabilities	IDR 225.4B
Debt	IDR 267.5B
Debt EBITDA	IDR 0.53
Debt Equity	IDR 0.09
Debt FCF	IDR 1.19
Equity	IDR 2.9T
Interest Coverage	24.41
Liabilities	IDR 470.2B
Long Term Assets	IDR 824.1B
Long Term Liabilities	IDR 244.7B
Net Cash	IDR 1.1T
Net Cash By Market Cap	IDR 19.39
Net Cash Growth	-6.7%
Net Debt EBITDA	IDR -2.24
Net Debt Equity	IDR -0.39
Net Debt FCF	IDR -4.88
Tangible Book Value	IDR 2.8T
Tangible Book Value Per Share	IDR 104
WACC	4.81

Metric	Value
Current ratio	11.08
Inventory Turnover	1.91
Net Working Capital	IDR 955B
Quick ratio	7.41
Working Capital	IDR 2.3T
Working Capital Turnover	IDR 1.03

Metric	Value
Buyback Yield	0.11%
Dividend Growth	14.29%
Dividend Growth Years	1%
Dividend per share	IDR 3.57
Dividend Years	4
Dividend Yield	1.7%
Ex Div Date	2026-06-18
Last Dividend	IDR 4.08
Payout Frequency	Annual
Payout Ratio	24.6%

Metric	Value
1Y total return	22.43%
200-day SMA	221.4
3Y total return	19.99%
50-day SMA	212.3
50-day SMA vs 200-day SMA	50under200
All Time High	318
All Time High Change	-33.96%
All Time High Date	2026-04-16
All Time Low	143
All Time Low Change	46.85%
All Time Low Date	2025-03-03
ATR	11.18
Beta	0.1
Beta1y	0.67
Beta2y	0.52
Ch YTD	1.94
High	216
High52	318
High52 Date	2026-04-16
High52ch	-33.96%
Low	206
Low52	174
Low52 Date	2025-07-29
Low52ch	23.53%
Ma50ch	-1.09%
Price vs 200-day SMA	-5.16%
RSI	52.19
RSI Monthly	49.06
RSI Weekly	46.59
Sharpe ratio	0.66x
Sortino ratio	1.08
Total Return	1.81%
Tr YTD	4
Tr1m	-0.94%
Tr1w	2.94%
Tr3m	-30.89%

Metric	Value
Analyst Count	2
Analyst Ratings	Buy
Operating Income	IDR 435B
Operating Income Growth	29.97
Operating Income Growth Q	67.76
Operating Income Growth3 Y	9.27
Operating margin	19.77
Price target	IDR 283
Price Target Change	IDR 34.76

Metric	Value
Float	3,951,005,100%
Net Borrowing	64,624,773,339
Shares Insiders	1.91%
Shares Out	27,008,119,900
Shares Qo Q	-0.04%
Shares Yo Y	-0.11%

Metric	Value
Adjusted FCF	IDR 225.3B
Average Volume	30,690,455x
Bv Per Share	104.4
CAPEX	IDR -109.6B
Ch1m	-0.94
Ch1w	2.94
Ch1y	20
Ch3m	-32.26
Ch3y	13.51
Ch6m	-8.7
Change	-1.87%
Change From Open	-2.78
Close	214
Days Gap	0.93
Depreciation Amortization	55,741,606,209
Dollar Volume	2,562,966,000
Earnings Date	2026-07-29
EBIT	IDR 435B
EBITDA	IDR 490.7B
EPS	IDR 14.52
F Score	6
FCF	IDR 225.3B
FCF EV Yield	4.89x
FCF Per Share	IDR 8.34
Financing CF	-45,369,793,950
Fiscal Year End	December
Founded	2,000
Graham Number	184.67991
Graham Upside	-12.06
Income Tax	IDR 94.2B
Investing CF	-245,389,036,096
Is Primary Listing	1
Last Earnings Date	2025-10-29
Last Report Date	2026-03-31
Lynch Fair Value	IDR 215
Lynch Upside	2.37
Ma150	229.4
Ma150ch	-8.46%
Ma20	202.8
Ma20ch	3.55%
Net CF	22,798,430,017
Next Earnings Date	2026-07-29
Open	216
P FCF Ratio	25.18
P OCF Ratio	16.94
Payment Date	2026-07-09
Position In Range	40
Ppne	540,300,561,359
Price Date	2026-07-24
Price EBITDA	IDR 11.56
Ptbv Ratio	2.01
Relative Volume	0.37x
Revenue	2,199,749,721,880x
Tax By Revenue	4.28x
Tax Rate	19.27%
Tr6m	-6.85%
Volume	12,204,600
Z Score	9.47